98.41
前日終値:
$96.50
開ける:
$94.85
24時間の取引高:
2.20M
Relative Volume:
1.33
時価総額:
$7.51B
収益:
$8.10B
当期純損益:
$599.48M
株価収益率:
13.30
EPS:
7.3969
ネットキャッシュフロー:
$971.50M
1週間 パフォーマンス:
+22.89%
1か月 パフォーマンス:
-46.11%
6か月 パフォーマンス:
-45.22%
1年 パフォーマンス:
-48.56%
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ICLR
Icon Plc
|
98.41 | 7.37B | 8.10B | 599.48M | 971.50M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2026-02-12 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | ダウングレード | Truist | Buy → Hold |
| 2025-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-09-09 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-03 | アップグレード | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-07-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-04-14 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-03-21 | ダウングレード | Goldman | Buy → Neutral |
| 2025-01-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 開始されました | Redburn Atlantic | Neutral |
| 2024-09-18 | 開始されました | Leerink Partners | Outperform |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2023-12-15 | 開始されました | Truist | Buy |
| 2023-09-13 | 開始されました | TD Cowen | Outperform |
| 2023-01-17 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-01-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-11-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-09-07 | 開始されました | UBS | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2021-09-27 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-14 | 開始されました | Citigroup | Neutral |
| 2021-04-13 | 再開されました | BofA Securities | Neutral |
| 2021-04-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 開始されました | Barclays | Equal Weight |
| 2021-03-01 | アップグレード | UBS | Neutral → Buy |
| 2021-02-26 | アップグレード | Truist | Hold → Buy |
| 2020-07-24 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-04-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 開始されました | Deutsche Bank | Hold |
| 2020-01-27 | ダウングレード | SunTrust | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-09-23 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | アップグレード | UBS | Sell → Neutral |
| 2019-01-25 | アップグレード | Mizuho | Neutral → Buy |
| 2018-10-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 開始されました | UBS | Sell |
| 2018-04-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 繰り返されました | Mizuho | Neutral |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
| 2017-10-27 | 繰り返されました | Barclays | Equal Weight |
| 2017-09-11 | 開始されました | BofA/Merrill | Buy |
| 2017-07-31 | アップグレード | SunTrust | Hold → Buy |
| 2017-07-27 | 繰り返されました | Mizuho | Neutral |
| 2017-06-29 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Icon Plc (ICLR) 最新ニュース
73,467 Shares in Icon Plc $ICLR Purchased by Muhlenkamp & Co. Inc. - MarketBeat
TD Cowen upgrades ICON stock on valuation after accounting probe By Investing.com - Investing.com Nigeria
ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Icon plc: Accounting Probe Sell-Off Creates Compelling Value Despite Modest EPS Impact - TipRanks
2026-02-18 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON plc (ICLR) and Encourages Investors to Learn More About the Investigation | NDAQ:ICLR | Press Release - Stockhouse
ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement - GuruFocus
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer - Benzinga
TD Cowen upgrades ICON stock on valuation after accounting probe - Investing.com
Icon Plc $ICLR Shares Sold by Eagle Health Investments LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON plc (ICLR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
ICON Faces Investor Lawsuit Investigation - Intellectia AI
ICON (ICLR) stock slides as Rothschild Redburn cuts rating, extending pressure from accounting probe - Bez Kabli
Icon PLC headcount plummets 1,800 in a year amid ‘strong cost control’ - MSN
ICLR ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ICON pcl Investors to Recover Losses - TradingView
Rothschild downgrades ICON stock on accounting investigation By Investing.com - Investing.com
ICON plc (ICLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ICON plc (ICLR) Stock Analysis: Unveiling an 87.74% Potential Upside in Healthcare Diagnostics - DirectorsTalk Interviews
Clinical Research Provider Icon Stock Crashes On Accounting Probe - AOL.com
ICON (ICLR) Is Down 38.2% After Internal Revenue Probe And Pulled 2025 OutlookWhat's Changed - simplywall.st
Market briefs: ECB extends interest rate pause and Birkenstock misses estimate - Business Post
ICON Public Limited Company (ICLR) Delays Earnings Amid Internal Investigation - Finviz
Icon’s Price Target Revisions Amid Strategic Expansions and New Partnerships - timothysykes.com
US law firms circle Icon PLC after revelations of accounting probe send shares plunging - The Irish Independent
ICON PLC (ICON) soars 16% as analyst issues 'hold', $93 PT despite accounting concerns - MSN
ICON PLC (ICON) Soars 16% as Analyst Issues 'Hold', $93 PT Despite Accounting Concerns - Finviz
ICON PLC (ICON) Soars 16% as Analyst Issues ‘Hold’, $93 PT Despite Accounting Concerns - Insider Monkey
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ICON (ICLR) stock rebounds after accounting probe shock — what investors watch next - Bez Kabli
ICON plc Expands Oncology Research, Sets New Price Target - StocksToTrade
Icon Strategy Expands with New Partnership to Bolster Oncology Research - timothysykes.com
ICON Expands Oncology Research Capabilities Amidst Positive Stock Reevaluation - StocksToTrade
ICON plc Expands Clinical Trial Capabilities through Strategic Partnership - timothysykes.com
Icon Partners with Brian Moran for Key Oncology Expansion - StocksToTrade
ICON plc Expands Oncology Network, Stock Assessment and Market Analysis - timothysykes.com
ICON plc Expands Oncology Research, Price Target Upgraded - StocksToTrade
ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition IssuesHagens Berman - The Malaysian Reserve
ICON (ICLR) Is Down 44.9% After Probing Revenue Recognition And Control WeaknessesWhat's Changed - Yahoo Finance
Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating - 富途牛牛
ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Inv - GuruFocus
ICON (ICLR) stock steadies premarket after 40% crash on accounting probe — what’s next - Bez Kabli
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICON plc (ICLR) And Encourages Investors to Reach Out - ACCESS Newswire
Icon PLC stock hits 52-week low at $79.49 By Investing.com - Investing.com Australia
Here's How Much $100 Invested In Icon 20 Years Ago Would Be Worth Today - Sahm
ICON stock plummets after accounting investigation delays earnings By Investing.com - Investing.com
ICON stock rating suspended by Evercore amid accounting investigation By Investing.com - Investing.com Canada
ICON stock rating downgraded by BofA Securities amid accounting concerns - Investing.com UK
Ademi LLP Investigates Claims of Securities Fraud against ICON plc - The Malaysian Reserve
ICON Public Limited Company Under Investigation for Securities Law Violations - Intellectia AI
ICON plc Shares Plunge 49% Amid Revenue Recognition Investigation - Intellectia AI
ICON plc (ICLR) Shares Crater Amid Delayed Financial - GlobeNewswire
Medtech Plummets 40% On Profit-Threatening Investigation - Investor's Business Daily
Icon Plc (ICLR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):